Results 331 to 340 of about 1,827,024 (396)
Strengthening advanced therapy for sickle cell disease in Africa: experience from sickle cell disease centre in Dar es Salaam, Tanzania. [PDF]
Bukini D+19 more
europepmc +1 more source
End points for sickle cell disease clinical trials: Renal and cardiopulmonary, cure, and low-resource settings [PDF]
al., et+2 more
core +1 more source
The association between underlying haematological disease, age at splenectomy and post‐splenectomy complications was explored among 1348 splenectomized patients, followed in 53 clinical centres with a median follow‐up time of 13 years and affected by transfusion‐dependent thalassaemia (TDT), non‐transfusion‐dependent thalassaemia (NTDT), sickle cell ...
Maddalena Casale+44 more
wiley +1 more source
Usage of a Multipurpose mHealth App Among Adults With Sickle Cell Disease: Randomized Controlled Trial. [PDF]
Cronin RM+7 more
europepmc +1 more source
The role of red blood cell characteristics and viscosity in sickle cell retinopathy and maculopathy
Sickle cell retinopathy and maculopathy are common ocular complications of sickle cell disease. This study assessed the contribution of red blood cell characteristics and blood viscosity to their development. HbSC patients with proliferative retinopathy showed a lower delta elongation index and point of sickling, while no link was found between whole ...
Rajani P. Brandsen+8 more
wiley +1 more source
ABSTRACT Due to the highly controlled settings of clinical trials, enrolled subjects may not be fully representative in age, gender, ethnicity, medical status, or socioeconomic background of the variety of patients who will ultimately receive a medication. This disconnect can lead to post‐approval challenges, the most substantial of which could include
Ananth Kadambi+7 more
wiley +1 more source
Assessing Major Organ Dysfunction in Children With Sickle Cell Disease: Protocol for a Cross-Sectional Study. [PDF]
Paintsil V+13 more
europepmc +1 more source
The Heat Is On: Climate Change Implications for Pregnant Women with Sickle Cell Disease. [PDF]
Chanmany Pastor R+3 more
europepmc +1 more source